BECTON, DICKINSON AND COMPANY Gross Profit
BECTON, DICKINSON AND COMPANY (BDX) reported Gross Profit of $2.21 billion for the 3-month period ending 2020-09-30, per its 10-K filed 2020-11-25.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2020-11-25
- BECTON, DICKINSON AND COMPANY gross profit for the quarter ending 2020-09-30 was $2.21B, a 2.65% decline year-over-year.
- BECTON, DICKINSON AND COMPANY gross profit for the quarter ending 2020-06-30 was $1.66B, a 20.01% decline year-over-year.
- BECTON, DICKINSON AND COMPANY gross profit for the quarter ending 2020-03-31 was $1.73B, a 12.16% decline year-over-year.
- BECTON, DICKINSON AND COMPANY gross profit for the quarter ending 2019-12-31 was $1.98B, a 0.20% increase year-over-year.
- BECTON, DICKINSON AND COMPANY gross profit for fiscal 2020 was $7.58B, a 8.58% decline from fiscal 2019.
- BECTON, DICKINSON AND COMPANY gross profit for fiscal 2019 was $8.29B, a 14.02% increase from fiscal 2018.
- BECTON, DICKINSON AND COMPANY gross profit for fiscal 2018 was $7.27B, a 22.33% increase from fiscal 2017.
- BECTON, DICKINSON AND COMPANY gross profit for fiscal 2017 was $5.94B, a 0.82% decline from fiscal 2016.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month | Gross Profit 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-09-30 | $2.21B 10-K · filed 2020-11-25 | $3.87B derived: sum of 2 quarters · filed 2020-11-25 | $5.60B derived: sum of 3 quarters · filed 2020-11-25 | $7.58B 10-K · filed 2020-11-25 | ||
| 2020-06-30 | $1.66B 10-K · filed 2020-11-25 | $3.39B derived: sum of 2 quarters · filed 2020-11-25 | $5.37B derived: sum of 3 quarters · filed 2020-11-25 | $7.64B derived: sum of 4 quarters · filed 2020-11-25 | ||
| 2020-03-31 | $1.73B 10-K · filed 2020-11-25 | $3.71B derived: sum of 2 quarters · filed 2020-11-25 | $5.98B derived: sum of 3 quarters · filed 2020-11-25 | $8.05B derived: sum of 4 quarters · filed 2020-11-25 | ||
| 2019-12-31 | $1.98B 10-K · filed 2020-11-25 | $4.24B derived: sum of 2 quarters · filed 2020-11-25 | $6.32B derived: sum of 3 quarters · filed 2020-11-25 | $8.29B derived: sum of 4 quarters · filed 2020-11-25 | ||
| 2019-09-30 | $2.27B 10-K · filed 2020-11-25 | $4.34B derived: sum of 2 quarters · filed 2020-11-25 | $6.31B derived: sum of 3 quarters · filed 2020-11-25 | $8.29B 10-K · filed 2020-11-25 | ||
| 2019-06-30 | $2.07B 10-K · filed 2020-11-25 | $4.05B derived: sum of 2 quarters · filed 2020-11-25 | $6.02B derived: sum of 3 quarters · filed 2020-11-25 | $8.12B derived: sum of 4 quarters · filed 2020-11-25 | ||
| 2019-03-31 | $1.97B 10-K · filed 2020-11-25 | $3.95B derived: sum of 2 quarters · filed 2020-11-25 | $6.04B derived: sum of 3 quarters · filed 2020-11-25 | $8.06B derived: sum of 4 quarters · filed 2020-11-25 | ||
| 2018-12-31 | $1.97B 10-K · filed 2020-11-25 | $4.07B derived: sum of 2 quarters · filed 2020-11-25 | $6.08B derived: sum of 3 quarters · filed 2020-11-25 | $7.69B derived: sum of 4 quarters · filed 2020-11-25 | ||
| 2018-09-30 | $2.09B 10-K · filed 2019-11-27 | $2.09B 10-K · filed 2018-11-21 | $4.11B derived: sum of 2 quarters · filed 2019-11-27 | $5.72B derived: sum of 3 quarters · filed 2019-11-27 | $7.27B 10-K · filed 2019-11-27 | $7.26B 10-K · filed 2018-11-21 |
| 2018-06-30 | $2.02B 10-K · filed 2019-11-27 | $3.62B derived: sum of 2 quarters · filed 2019-11-27 | $5.18B derived: sum of 3 quarters · filed 2019-11-27 | $6.73B derived: sum of 4 quarters · filed 2019-11-27 | ||
| 2018-03-31 | $1.61B 10-K · filed 2019-11-27 | $1.60B 10-K · filed 2018-11-21 | $3.16B derived: sum of 2 quarters · filed 2019-11-27 | $4.71B derived: sum of 3 quarters · filed 2019-11-27 | $6.22B derived: sum of 4 quarters · filed 2019-11-27 | |
| 2017-12-31 | $1.55B 10-K · filed 2019-11-27 | $1.55B 10-K · filed 2018-11-21 | $3.11B derived: sum of 2 quarters · filed 2019-11-27 | $4.61B derived: sum of 3 quarters · filed 2019-11-27 | $6.04B derived: sum of 4 quarters · filed 2019-11-27 | |
| 2017-09-30 | $1.55B 10-K · filed 2018-11-21 | $3.06B derived: sum of 2 quarters · filed 2018-11-21 | $4.49B derived: sum of 3 quarters · filed 2018-11-21 | $5.94B 10-K · filed 2018-11-21 | ||
| 2017-06-30 | $1.50B 10-K · filed 2018-11-21 | $2.94B derived: sum of 2 quarters · filed 2018-11-21 | $4.39B derived: sum of 3 quarters · filed 2018-11-21 | $5.94B derived: sum of 4 quarters · filed 2018-11-21 | ||
| 2017-03-31 | $1.43B 10-K · filed 2018-11-21 | $2.88B derived: sum of 2 quarters · filed 2018-11-21 | $4.44B derived: sum of 3 quarters · filed 2018-11-21 | $5.98B derived: sum of 4 quarters · filed 2018-11-21 | ||
| 2016-12-31 | $1.45B 10-K · filed 2018-11-21 | $3.00B derived: sum of 2 quarters · filed 2018-11-21 | $4.55B derived: sum of 3 quarters · filed 2018-11-21 | $6.04B derived: sum of 4 quarters · filed 2018-11-21 | ||
| 2016-09-30 | $1.55B 10-K · filed 2017-11-22 | $3.10B derived: sum of 2 quarters · filed 2017-11-22 | $4.58B derived: sum of 3 quarters · filed 2017-11-22 | $5.99B 10-K · filed 2017-11-22 | ||
| 2016-06-30 | $1.55B 10-K · filed 2017-11-22 | $3.03B derived: sum of 2 quarters · filed 2017-11-22 | $4.44B derived: sum of 3 quarters · filed 2017-11-22 | $5.87B derived: sum of 4 quarters · filed 2017-11-22 | ||
| 2016-03-31 | $1.48B 10-K · filed 2017-11-22 | $2.89B derived: sum of 2 quarters · filed 2017-11-22 | $4.32B derived: sum of 3 quarters · filed 2017-11-22 | $5.50B derived: sum of 4 quarters · filed 2017-11-22 | ||
| 2015-12-31 | $1.41B 10-K · filed 2017-11-22 | $2.84B derived: sum of 2 quarters · filed 2017-11-22 | $4.01B derived: sum of 3 quarters · filed 2017-11-22 | $5.06B derived: sum of 4 quarters · filed 2017-11-22 | ||
| 2015-09-30 | $1.43B 10-K · filed 2016-11-23 | $2.60B derived: sum of 2 quarters · filed 2016-11-23 | $3.65B derived: sum of 3 quarters · filed 2016-11-23 | $4.70B 10-K · filed 2016-11-23 | ||
| 2015-06-30 | $1.17B 10-K · filed 2016-11-23 | $2.22B derived: sum of 2 quarters · filed 2016-11-23 | $3.27B derived: sum of 3 quarters · filed 2016-11-23 | $4.37B derived: sum of 4 quarters · filed 2016-11-23 | ||
| 2015-03-31 | $1.05B 10-K · filed 2016-11-23 | $2.09B derived: sum of 2 quarters · filed 2016-11-23 | $3.19B derived: sum of 3 quarters · filed 2016-11-23 | $4.30B derived: sum of 4 quarters · filed 2016-11-23 | ||
| 2014-12-31 | $1.04B 10-K · filed 2016-11-23 | $2.15B derived: sum of 2 quarters · filed 2016-11-23 | $3.26B derived: sum of 3 quarters · filed 2016-11-23 | $4.31B derived: sum of 4 quarters · filed 2016-11-23 | ||
| 2014-09-30 | $1.10B 10-K · filed 2015-11-25 | $2.21B derived: sum of 2 quarters · filed 2015-11-25 | $3.27B derived: sum of 3 quarters · filed 2015-11-25 | $4.30B 10-K · filed 2015-11-25 | ||
| 2014-06-30 | $1.11B 10-K · filed 2015-11-25 | $2.16B derived: sum of 2 quarters · filed 2015-11-25 | $3.20B derived: sum of 3 quarters · filed 2015-11-25 | |||
| 2014-03-31 | $1.05B 10-K · filed 2015-11-25 | $2.09B derived: sum of 2 quarters · filed 2015-11-25 | ||||
| 2013-12-31 | $1.03B 10-K · filed 2015-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |